S. Horlait

A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis

E. Michael Lewiecki, Tomasz Blicharski, Stefan Goemaere et al. · The Journal of Clinical Endocrinology & Metabolism · 2018 · 301 citations · Full text

Efficacy of risedronate on clinical vertebral fractures within six months

Christian Roux, Ego Seeman, Richard Eastell et al. · Current Medical Research and Opinion · 2004 · 184 citations

Randomized Trial of Effect of Cyclical Etidronate in the Prevention of Corticosteroid-Induced Bone Loss

Christian Roux, Pasquale Oriente, Roland Laan et al. · The Journal of Clinical Endocrinology & Metabolism · 1998 · 167 citations

The severity of vertebral fractures and health-related quality of life in osteoporotic postmenopausal women

J. Fechtenbaum, Claire Cropet, S. Kolta et al. · Osteoporosis International · 2005 · 123 citations

Bone Disease, Quality Of Life, Skeletal Trauma +10

Effect of the new dopaminergic agonist CV 205–502 on plasma prolactin levels and tumour size in bromocriptine‐resistant prolactinomas

Lise Duranteau, P. Chanson, Alain Lavoinne et al. · Clinical Endocrinology · 1991 · 61 citations